CDXS - MCAP CO - Codexis, Inc.

This price chart for Codexis, Inc. (CDXS), which has a market capitalization of 0.15, illustrates the price action of the bioengineered protein developer. The business is exposed to risks from trade conflicts and raw material supply chain disruptions. Codexis, Inc. (CDXS) relies on partnerships with the food and medical sectors to create custom enzymes, while multi-year licensing agreements with pharmaceutical behemoths ensure a stable cash flow.

The market capitalization of Codexis, Inc. (CDXS) reflects the market valuation of its unique DNA technologies and patent protection. This metric is calculated as the product of the current share price and the total number of outstanding securities. By analyzing the company's market value on the exchange, an investor sees the consensus regarding the cost of its integration into pharmaceutical production. High customer switching costs support the stability of this metric. This chart's price action allows for the distinction between fundamental growth and temporary speculation.